Tiny extracellular vesicles that carry information from one cell to another may contribute to the development of idiopathic pulmonary fibrosis (IPF) by carrying molecules involved in the disease, a study has found. The study, “Increased Extracellular Vesicles Mediate WNT-5A Signaling in Idiopathic Pulmonary Fibrosis,” was published in the…
Extracellular Vesicles Likely Play Role in IPF Development, Study Reports
Most of us receive our medical care from our primary care doctor or a local pulmonologist. However helpful they may be, they don’t know everything about the rare disease that we have. Four years ago, the first pulmonologist I saw told me I had a few months to…
Lung cancer and acute exacerbations are significant predictors of mortality in patients with combined pulmonary fibrosis and emphysema, according to researchers. Their study, “Presence of lung cancer and high gender, age, and physiology score as predictors of acute exacerbation in combined pulmonary fibrosis and emphysema: A…
Any chronic illness diagnosis is scary and confusing. It is a time filled with an abundance of emotions that are difficult to navigate. Unfortunately, these emotions don’t exist only for the first few months after a diagnosis, but rather they remain ever-present as a patient learns to live…
A recent study has provided more insight into the molecular processes that might be involved in the pathological changes that take place in the lungs of patients with idiopathic pulmonary fibrosis (IPF). In the study, “A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis,”…
I’ll be transparent: Living with a chronic illness sucks, regardless of the disease you deal with. It’s not easy learning to navigate life while sick, and unfortunately, there is no rulebook to study. I can only speak for all the difficulties that come with having idiopathic pulmonary fibrosis…
Pliant Therapeutics announced that its lead therapy candidate PLN-74809 was designated an orphan drug by the U.S. Food and Drug Administration (FDA), an act that helps to advance its development as a possible treatment of…
Being diagnosed with pulmonary fibrosis is not for the faint of heart. It is a rough road full of fears, losses, and unknowns. It’s difficult getting used to all that comes with this diagnosis, including lots of up and downs, tears, disbelief, and attempts to adjust. Taking good care…
Adding Ofev (nintedanib) to Esbriet (pirfenidone) for idiopathic pulmonary fibrosis (IPF) is tolerated by most patients and has a similar safety profile as taking each medication alone,…
The presence of swollen lymph nodes in patients with idiopathic pulmonary fibrosis (IPF) at the time of their diagnosis can be a predictor of poor prognosis, associated with stronger disease severity and lower survival, a study suggests.
